19096-Rectal Cancer-NA-524

Rectal Cancer

An Open-label, Single-arm, Phase II Study of Regorafenib and Nivolumab in Patients With Mismatch Repair-Proficient (pMMR)/Microsatellite Stable (MSS) Colorectal Cancer (CRC)(20975)

  • Details

ClinicalTrials.gov ID: NCT04126733
Diagnosis Type: NA
USOR Number: 19096

  • Address

2800 Highway 75 North
Sherman, TX 75090
P: (903) 868-4700

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.